SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Health Technology Assessment in Health-Care Decisions in the United States
6 references·3 citing·33 second hop
Health Technology Assessment in Health-Care Decisions in the United States (2009)Health Technology Assessment in Health-Ca…Developing A Center For Comparative Effectiveness Information (2006)Developing A Center For Compa…Coverage Options For Promising Technologies: Medicare’s ‘Coverage With Evidence Development’ (2006)Coverage Options For Promisin…Medicare and Cost-Effectiveness Analysis (2005)Medicare and Cost-Effectivene…Health Care Cost, Quality, and Outcomes. ISPOR Book of Terms. (2003)Health Care Cost, Quality, an…New challenge or the past revisited? (1995)New challenge or the past rev…Assessing Medical Technologies (1985)Assessing Medical TechnologiesOriginal Abstracts from the 15th Annual Meeting of ISMPP (2019)Original Abstracts from the 1…Comparison of Anticancer Drug Coverage Decisions in the United States and United Kingdom: Does the Evidence Support the Rhetoric? (2010)Comparison of Anticancer Drug…Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations? (2010)Are Key Principles for improv…The Congressional Quarterly (1950)The almanac of American politics: 1978 (1978)Governing by Values. EU Ethics: Soft Tool, Hard Effects (2009)Embracing variety: introducing the inclusive modelling of (Parliamentary) technology assessment (2014)Office of Technology Assessment: History, implementation, and participatory critique (2015)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)The Role of Cost-effectiveness Analysis in Health and Medicine (1996)The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine (1996)Biologic drugs for rheumatoid arthritis in the medicare program: A cost‐effectiveness analysis (2008)Cancer Therapy Costs Influence Treatment: A National Survey Of Oncologists (2010)When is Cancer Care Cost-Effective? A Systematic Overview of Cost–Utility Analyses in Oncology (2010)Centralized Drug Review Processes In Australia, Canada, New Zealand, And The United Kingdom (2006)Information on Cost-Effectiveness: An Essential Product of a National Comparative Effectiveness Program (2008)Facts, Fallacies, and Politics of Comparative Effectiveness Research: Part 2 - Implications for Interventional Pain Management (2010)What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation? (2003)Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs (2009)Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial (2011)Cancer economics, policy and politics: What informs the debate? Perspectives from the EU, Canada and US (2014)BEST PRACTICE IN UNDERTAKING AND REPORTING HEALTH TECHNOLOGY ASSESSMENTS (2002)Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems) (2006)Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)#AdvocatingForChange: The Strategic Use of Hashtags in Social Media Advocacy (2015)CARE guidelines for case reports: explanation and elaboration document (2017)Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)Cost-effectiveness of insulin analogues for diabetes mellitus (2009)Health Technology Assessment: Lessons Learned from Around the World—An Overview (2009)Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt (2013)Coverage with Evidence Development: An examination of conceptual and policy issues (2007)Funding the Unfundable (2010)Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers (2010)Focusing Technology Assessment Using Medical Decision Theory (1988)Measuring the effects of imaging: An evaluative framework (1995)When and how to assess fast-changing technologies: a comparative study of medical applications of four generic technologies. (1997)
this work references cited by second hop

References

  • 2005Medicare and Cost-Effectiveness Analysis225 cited
  • 2006Coverage Options For Promising Technologies: Medicare’s ‘Coverage With Evidence Development’210 cited
  • 1985Assessing Medical Technologies185 cited
  • 2003Health Care Cost, Quality, and Outcomes. ISPOR Book of Terms.139 cited
  • 2006Developing A Center For Comparative Effectiveness Information135 cited
  • 1995New challenge or the past revisited?34 cited

Cited by

  • 2010Comparison of Anticancer Drug Coverage Decisions in the United States and United Kingdom: Does the Evidence Support the Rhetoric?77 cited
  • 2010Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?69 cited
  • 2019Original Abstracts from the 15th Annual Meeting of ISMPP6 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work